Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/03/2010US7767707 Fused pyrazolyl compounds having an aminoalkylcarbonyl group
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767705 Compounds that inhibit TRPV1 and uses thereof
08/03/2010US7767704 viricides such as N-(3-Chloropropyl)-1-methyl-4-[({[4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-1H-imidazol-2-carboxamide, used for treating cytomegalovirus infections in humans or animals
08/03/2010US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders
08/03/2010US7767701 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia
08/03/2010US7767700 Controlling dosage; side effect reduction
08/03/2010US7767699 Therapeutic agents useful for treating pain
08/03/2010US7767698 A pharmaceutical liquid comprising nicotine, a buffer or pH controller; spraying an aerosol into the mouth for deliverying into the lungs, for treating tobacco addiction; new pharmaceutical formulation
08/03/2010US7767697 Factor Xa inhibitors
08/03/2010US7767696 Antitumor agents; tyrosine inhbitor; controllling kinase signal transduction
08/03/2010US7767695 Substituted piperidines
08/03/2010US7767694 treating gastrointestinal motility disorders by administering O-(3-piperidino-2-hydroxypropyl) nicotinic amidoxime; inflammatory bowel disease; restores and/or enhances the activity of the neuronal nitric oxide synthase
08/03/2010US7767693 inhibition of heat shock protein 90 (HSP90) comprising administering benzoyl compounds or prodrugs,as antitumor agents
08/03/2010US7767692 1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
08/03/2010US7767690 Amino alcohol derivatives and their use as renin inhibitor
08/03/2010US7767689 Carboline derivatives useful in the treatment of cancer
08/03/2010US7767688 Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours
08/03/2010US7767687 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
08/03/2010US7767686 administering antagonists such as 8-(p-sulfophenyl)theophylline and N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,7-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide
08/03/2010US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects
08/03/2010US7767684 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide
08/03/2010US7767683 Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament
08/03/2010US7767682 Treatment of renal diseases or conditions associated with abnormal ion flux in a mammal such as a human which comprises the administration of a hPPAR gamma modulator or salt or solvate thereof, such as farglitazar or rosiglitazone
08/03/2010US7767681 chemokine receptor modulators such as N-[4-(2-methoxy-5-propoxyphenyl)thiazol-2-yl]-N'-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]urea, used for the prevention or treatment of asthma, arthritis, allergies, autoimmune diseases, atherosclerosis or angiogenesis
08/03/2010US7767680 4-phenylpyrimidine compounds such as 4-(2-Fluoro-phenyl)-2-morpholin-4-yl-pyrimidine-5-carboxylic acid benzyl-isopropyl-amide, useful as inhibitors of voltage-gated sodium channels and/or calcium channels, for the treatment of pain, psychological and neurodegenerative disorders
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767678 treating with hot water; pancreatic and prostate cancer
08/03/2010US7767677 Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767675 Imidazotriazines and imidazopyrimidines as kinase inhibitors
08/03/2010US7767674 Suppression cytokines, tumor necrosis factor
08/03/2010US7767673 N-substituted imidazopyridine c-Kit inhibitors
08/03/2010US7767672 Aminopyrimidines useful as kinase inhibitors
08/03/2010US7767671 3-Quinolinecarbonitrile protein kinase inhibitors
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer
08/03/2010US7767668 Micronized tanaproget, compositions, and methods of preparing the same
08/03/2010US7767667 Pesticidal heterocycles
08/03/2010US7767666 Butyl and butynyl benzyl amine compounds
08/03/2010US7767665 1,3-benzothiazinone derivatives and use thereof
08/03/2010US7767664 Plant growth regulation
08/03/2010US7767662 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents
08/03/2010US7767661 particularly tyrosinase; preventing and treating melanin overproduction; isolated from a plant family selected from the group consisting of Compositae, Fabaceae, Lauraceae, Leguminosae, Liliaceae, Loranthaceae, Moracea, and Myristicaceae
08/03/2010US7767660 Macrocyclic indole compounds, e.g., (7R)-14-cyclohexyl-21,24-dimethyl-7,8-dihydro-6H-7,11-(epiminoethanoiminopropanothio iminomethano)indolo[1,2-e][1,5]benzoxazocin-15-one 17,17-dioxide; hepatitis C virus polymerase inhibitors
08/03/2010US7767659 Synthesis of naturally occurring ecteinascidins and related compounds
08/03/2010US7767658 Vaccine composition
08/03/2010US7767657 Boron-containing small molecules
08/03/2010US7767656 Blends of temperature sensitive and anionic polymers for drug delivery
08/03/2010US7767655 High Molecular weight polysaccharide fraction from Aloe vera with immunostimulatory activity
08/03/2010US7767654 treating bleeding disorder selected from a chronic or acute bleeding disorder, a congenital coagulation disorder caused by a blood factor deficiency, and an acquired coagulation disorder, by administering a composition comprising a procoagulant amount of a fucoidan
08/03/2010US7767652 comprising a substrate and an active agent associated with substrate, wherein active agent suppresses production and/or activity of a TLH enzyme in collagen-producing cells and comprises a siRNA molecule or a DNA that encodes a siRNA molecule, wherein siRNA molecule inhibits translation of a TLH enzyme
08/03/2010US7767650 Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
08/03/2010US7767646 Drug screening for thrombin activatable fibrinolysis inhibitor modulators; ortho-hydroxybenzamides; anticoagulants; finding that aspirin and derivatives salicylic acid ("SA") and salicyluric acid ("SU"), promote fibrinolysis by inhibiting TAFIa enzymatic activity and by inhibiting activation of TAFI
08/03/2010US7767626 3-arylphenyl sulfide derivative and insecticide and miticide
08/03/2010US7767456 Non-viral gene delivery system
08/03/2010US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename
08/03/2010US7767427 Production method of oil or fat containing polyunsaturated fatty acid-containing triglyceride
08/03/2010US7767417 Prenyl-electrostatic switch, and methods of use
08/03/2010US7767398 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders
08/03/2010US7767397 Hepoxilins and modulators of ichthyin for treatment skin disorders
08/03/2010US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
08/03/2010US7767236 safflower seed extract prepared by washing a defatted safflower seed with water to obtain a washed product, separating the washed product from a resulting washing liquid, and extracting the washed product with an organic solvent; for reducing risk of developing atherosclerosis
08/03/2010US7767232 Control of nitric oxide bioactivity by perfluorocarbons
08/03/2010US7767231 pharmaceutical composition comprising taste-masked coated particles comprising a macrolide antibiotic, preferably clarithromycin, which is in the form of a suspension which maintains its palatability over a prolonged period of time by means of defined osmotic conditions
08/03/2010US7767230 Organic compounds
08/03/2010US7767229 Use of poly diallyamine polymers
08/03/2010US7767228 Pharmaceutical composition for oral application and method for preparing thereof
08/03/2010US7767227 Galenical form for oral administration with prolonged release of molsidomine
08/03/2010US7767224 Method for the continuous production and coating of self-adhesive compounds on the basis of SBC that includes at least one pharmaceutically active substance
08/03/2010US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
08/03/2010US7767217 Ophthalmic compositions comprising povidone-iodine
08/03/2010US7767215 Topical compositions for anti-aging and methods of using same
08/03/2010US7767208 Noninvasive vascular therapy
08/03/2010US7767204 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
08/03/2010US7767197 Immunogen formulation comprising antigen, polymer and liquid vehicle for stimulation of an immune response when administered to a host
08/03/2010US7767195 neurophysiological assay using information obtained from injecting a neural activity blocker, such as tetrodotoxin, into one hippocampus persistently coactivated pyramidal cell in the uninjected hippocampus that initially discharged independently
08/03/2010US7766013 Aerosol generating method and device
08/03/2010CA2677670C Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/03/2010CA2661728C Generation of therapeutic microfoam
08/03/2010CA2649893C Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
08/03/2010CA2612742C Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof
08/03/2010CA2610873C Tetrahydroquinolines and their use as modulators of metabotropic glutamate receptors
08/03/2010CA2598788C Indoline-sulfonamides compounds
08/03/2010CA2572359C Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
08/03/2010CA2528622C Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders
08/03/2010CA2526228C Quinoline derivatives as phosphodiesterase inhibitors
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2503201C Modified release compositions of milnacipran
08/03/2010CA2502582C Pharmaceutical formulation of olanzapine
08/03/2010CA2492724C The use of epidermal growth factor as a gastrointestinal therapeutic agent
08/03/2010CA2490191C Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections
08/03/2010CA2480080C Composition for cell proliferation
08/03/2010CA2476622C A transdermal patch
08/03/2010CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/03/2010CA2455064C Transdermal therapeutic system based on polyacrylate contact adhesives without functional groups
08/03/2010CA2444269C Treatment of disorders secondary to organic impairments
08/03/2010CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction
08/03/2010CA2436287C Fast dissolving tablet
1 ... 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 ... 7860